Contemporary Treatment Patterns and Clinical Outcomes of Comorbid Diabetes Mellitus and HFrEF
- 6 May 2020
- journal article
- research article
- Published by Elsevier BV in JACC: Heart Failure
- Vol. 8 (6), 469-480
- https://doi.org/10.1016/j.jchf.2019.12.015
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Cardiovascular Mortality in Patients With Type 2 Diabetes and Recent Acute Coronary Syndromes From the EXAMINE TrialDiabetes Care, 2016
- Evaluating the Quality of Comprehensive Cardiometabolic Care for Patients With Type 2 Diabetes in the U.S.: The Diabetes Collaborative RegistryDiabetes Care, 2016
- Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium–Glucose Cotransporter 2 InhibitionDiabetes Care, 2015
- Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trialThe Lancet, 2015
- Heart failure: a cardiovascular outcome in diabetes that can no longer be ignoredThe Lancet Diabetes & Endocrinology, 2014
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes MellitusThe New England Journal of Medicine, 2013
- Thiazolidinediones and Risk of Heart Failure in Patients with or at High Risk of Type 2 Diabetes MellitusAmerican Journal of Cardiovascular Drugs, 2011
- Systematic Review: Glucose Control and Cardiovascular Disease in Type 2 DiabetesAnnals of Internal Medicine, 2009
- Diabetic CardiomyopathyJAMA, 1974
- New type of cardiomyopathy associated with diabetic glomerulosclerosisThe American Journal of Cardiology, 1972